← Back to headlines
Dyne Therapeutics Stock Slips After Upsized $375M Public Offering
Dyne Therapeutics' stock slipped after the company priced an upsized $375 million public offering at $20.50 per share, following an earlier announcement of a $300 million stock offering that led to a 14% drop in shares.
22 Jul, 06:45 — 22 Jul, 06:45
Sources
Showing 1 of 1 sources
